News | MLL

Our newsletter is an offer of MLL Münchner Leukämielabor GmbH, Max-Lebsche-Platz 31, 81377 Munich (“MLL,” “we”) and contains information about our products and services, research results, events and other news relevant to the company and to the discipline, especially regarding diagnostics and subsequent therapy for leukemia and lymphoma. For you to subscribe, we need the e-mail address that you want us to send the newsletter to. We may use optional information to personalize how the addressee is addressed.
To continuously improve the quality of our newsletter and its contents, we conduct a pseudonymized analysis of the opening rate of the newsletter and information on calling up specific articles. You can find detailed information on how personal data is processed in connection with our newsletter in our Data protection information section.

By clicking on the “Subscribe to the newsletter” button, I consent to allow MLL to use the e-mail address and optional information provided by me for sending the newsletter and for addressing me personally.

You have the right to withdraw your consent at any time. Withdrawing your consent does not affect the lawfulness of the processing that took place based on your consent up until the time of withdrawal. One way you can withdraw your consent is by using the withdrawal function contained in every newsletter. Alternatively, you can declare that you are withdrawing your consent by sending an e-mail to presse@remove-this.mll.com or by mailing a letter to MLL Münchner Leukämielabor GmbH, Max-Lebsche-Platz 31, 81377 Munich.

Here you will find all MLL News as well as scientific contributions to leukemia diagnostics and research.

to the MLL Magazine

Dr. rer. nat. Christine Käppel
from 24.02.2021
MLL News
An ISO 14001 certified environmental management system for sustainable and environmentally friendly leukemia diagnostics
As a highly innovative company, we are well aware of the responsibility we bear for creating the world of tomorrow. With this in mind, we have successfully established an ISO 14001 based professional environmental management system in all of our sections and processes. In one assessment, our efforts were verified by the neutral and accredited certification body DEKRA (see ISO 14001 certificate).
Post review
Current rating is 5.0 out of 5

1

2

3

4

5
Read article
Prof. Dr. med. Dr. phil. Torsten Haferlach
from 24.02.2021
MLL News
62. ASH Annual Meeting & Exposition - a follow-up report
In December 2020, the 62nd Annual Meeting & Exposition of the American Society of Hematology (ASH) took place, for the first time in virtual format. At the world's largest hematology congress, international experts gathered for five days to exchange the latest hematology findings and learn about the current state of research. This time, too, the MLL Munich Leukemia Laboratory was there. A total of 12 scientists presented their current research projects. You can find out which ones in this article.
Post review
Current rating is 5.0 out of 5

1

2

3

4

5
Read article
Dr. med. Christian Dornes
from 24.02.2021
MLL News
Presentation: The MHP Munich Hematology Practice
The MLL Munich Leukemia Laboratory is generally associated with specialist hematological diagnostics and innovation. The MHP Munich Hematology Practice is another organ which is involved in insurance-funded and private medical care of patients in the Munich metropolitan area. In this article we would like to introduce you to MHP.
Post review
Current rating is 5.0 out of 5

1

2

3

4

5
Read article
Sarah Kurz
from 01.02.2021
MLL News
New iniative: Genomics for Next Generation Healthcare in Haematological Diseases
The consortium of GenoMed4All - Genomics and Personalised Medicine for all through Artificial Intelligence in Haematological Diseases is pleased to announce the launch of an ambitious joint initiative selected and granted by the European Commission under the Horizon 2020 Research & Innovation programme. The MLL Munich Leukemia Laboratory is also part of this initiative.
Post review
Current rating is 5.0 out of 5

1

2

3

4

5
Read article